Showing results (211-220 of 573) with videos related to
Sort By:
Pageof 58
Life Sciences|November 5, 1984
125I-Spiperone: a novel ligand for D2 dopamine receptorsA L Gundlach, B L Largent, S H SnyderMolecular Pharmacology|November 1, 1984
Anxiolytic cyclopyrrolone drugs allosterically modulate the binding of [35S]t-butylbicyclophosphorothionate to the benzodiazepine/gamma-aminobutyric acid-A receptor/chloride anionophore complexR R Trifiletti, A M Snowman, S H SnyderThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 1, 1985
Differential visualization of dopamine and norepinephrine uptake sites in rat brain using [3H]mazindol autoradiographyJ A Javitch, S M Strittmatter, S H SnyderProceedings of the National Academy of Sciences of the United States of America|April 1, 1985
Protein kinase C regulates ionic conductance in hippocampal pyramidal neurons: electrophysiological effects of phorbol estersJ M Baraban, S H Snyder, B E AlgerJournal of Cardiovascular Pharmacology|January 1, 1987
Physiological and pharmacological correlates of calcium antagonist receptorsJ A Wagner, I J Reynolds, S H SnyderProceedings of the National Academy of Sciences of the United States of America|June 1, 1971
A unique synaptosomal fraction, which accumulates glutamic and aspartic acids, in brain tissueA R Wofsey, M J Kuhar, S H SnyderThe Journal of Pharmacology and Experimental Therapeutics|August 1, 1986
Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidineB L Largent, A L Gundlach, S H SnyderThe Journal of Pharmacology and Experimental Therapeutics|June 1, 1986
(-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridinesI J Reynolds, A M Snowman, S H SnyderLancet (London, England)|April 27, 1985
Normal MPTP binding in parkinsonian substantial nigra: evidence for extraneuronal toxin conversion in human brainG R Uhl, J A Javitch, S H SnyderJournal of Neurochemistry|February 1, 1987
Characterization of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, to neuromelaninR J D'Amato, D F Benham, S H SnyderPageof 58